77 related articles for article (PubMed ID: 7621579)
21. Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigen.
Okazaki T; Pendleton CD; Lemonnier F; Berzofsky JA
J Immunol; 2003 Sep; 171(5):2548-55. PubMed ID: 12928405
[TBL] [Abstract][Full Text] [Related]
22. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.
Wizel B; Houghten R; Church P; Tine JA; Lanar DE; Gordon DM; Ballou WR; Sette A; Hoffman SL
J Immunol; 1995 Jul; 155(2):766-75. PubMed ID: 7541824
[TBL] [Abstract][Full Text] [Related]
23. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
[TBL] [Abstract][Full Text] [Related]
24. Heterologous protection against influenza by injection of DNA encoding a viral protein.
Ulmer JB; Donnelly JJ; Parker SE; Rhodes GH; Felgner PL; Dwarki VJ; Gromkowski SH; Deck RR; DeWitt CM; Friedman A
Science; 1993 Mar; 259(5102):1745-9. PubMed ID: 8456302
[TBL] [Abstract][Full Text] [Related]
25. Vaccines against human immunodeficiency virus--progress and prospects.
Letvin NL
N Engl J Med; 1993 Nov; 329(19):1400-5. PubMed ID: 8413438
[No Abstract] [Full Text] [Related]
26. HIV vaccination dilemma.
Sabin AB
Nature; 1993 Mar; 362(6417):212. PubMed ID: 8318105
[No Abstract] [Full Text] [Related]
27. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.
Parker KC; Bednarek MA; Coligan JE
J Immunol; 1994 Jan; 152(1):163-75. PubMed ID: 8254189
[TBL] [Abstract][Full Text] [Related]
28. Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes.
Zhou F; Huang L
Vaccine; 1993; 11(11):1139-44. PubMed ID: 8249434
[TBL] [Abstract][Full Text] [Related]
29. Multifactorial nature of human immunodeficiency virus disease: implications for therapy.
Fauci AS
Science; 1993 Nov; 262(5136):1011-8. PubMed ID: 8235617
[TBL] [Abstract][Full Text] [Related]
30. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules.
Ruppert J; Sidney J; Celis E; Kubo RT; Grey HM; Sette A
Cell; 1993 Sep; 74(5):929-37. PubMed ID: 8104103
[TBL] [Abstract][Full Text] [Related]
31. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
[TBL] [Abstract][Full Text] [Related]
32. A pattern search method for putative anchor residues in T cell epitopes.
Hobohm U; Meyerhans A
Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
[TBL] [Abstract][Full Text] [Related]
33. MHC molecules as peptide receptors.
Rammensee HG; Falk K; Rötzschke O
Curr Opin Immunol; 1993 Feb; 5(1):35-44. PubMed ID: 7680871
[TBL] [Abstract][Full Text] [Related]
34. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen.
Chen W; Carbone FR; McCluskey J
J Immunol Methods; 1993 Mar; 160(1):49-57. PubMed ID: 7680698
[TBL] [Abstract][Full Text] [Related]
35. Multispecific and heterogeneous recognition of the gag protein by cytotoxic T lymphocytes (CTL) from HIV-infected patients: factors other than the MHC control the epitopic specificities.
Buseyne F; Janvier G; Fleury B; Schmidt D; Rivière Y
Clin Exp Immunol; 1994 Sep; 97(3):353-60. PubMed ID: 7521806
[TBL] [Abstract][Full Text] [Related]
36. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
Kawakami Y; Eliyahu S; Sakaguchi K; Robbins PF; Rivoltini L; Yannelli JR; Appella E; Rosenberg SA
J Exp Med; 1994 Jul; 180(1):347-52. PubMed ID: 7516411
[TBL] [Abstract][Full Text] [Related]
37. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.
Cox AL; Skipper J; Chen Y; Henderson RA; Darrow TL; Shabanowitz J; Engelhard VH; Hunt DF; Slingluff CL
Science; 1994 Apr; 264(5159):716-9. PubMed ID: 7513441
[TBL] [Abstract][Full Text] [Related]
38. MHC class I H-2Kd-restricted antigenic peptides: additional constraints for the binding motif.
Eberl G; Sabbatini A; Servis C; Romero P; Maryanski JL; Corradin G
Int Immunol; 1993 Nov; 5(11):1489-92. PubMed ID: 7505110
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic T-cell immunity to influenza.
McMichael AJ; Gotch FM; Noble GR; Beare PA
N Engl J Med; 1983 Jul; 309(1):13-7. PubMed ID: 6602294
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.
Quinnan GV; Kirmani N; Rook AH; Manischewitz JF; Jackson L; Moreschi G; Santos GW; Saral R; Burns WH
N Engl J Med; 1982 Jul; 307(1):7-13. PubMed ID: 6281647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
